You can also argue that it is chicken and egg, and we want the clinical trials to be conducted (EMD AML with current formulation and the rest with new formulation starting in Q3 2023) before doing the marketing or you may give away a chunk of shares for lower valuation. If so, just tell me in the face that we are delayed by another 12 months on marketing if that is the case.
- Forums
- ASX - By Stock
- RAC
- Ann: Race 2022 AGM Presentations
Ann: Race 2022 AGM Presentations, page-7
-
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.63 |
Change
-0.050(2.98%) |
Mkt cap ! $276.0M |
Open | High | Low | Value | Volume |
$1.67 | $1.67 | $1.61 | $112.7K | 69.82K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1785 | $1.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.64 | 304 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1785 | 1.630 |
1 | 850 | 1.625 |
1 | 1233 | 1.620 |
2 | 2787 | 1.610 |
1 | 7500 | 1.605 |
Price($) | Vol. | No. |
---|---|---|
1.640 | 304 | 5 |
1.655 | 10753 | 2 |
1.660 | 463 | 1 |
1.670 | 5988 | 1 |
1.680 | 10129 | 3 |
Last trade - 11.35am 09/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |